Discovery of Amodiachins, a Novel Class of 4-Aminoquinoline Antimalarials Active against Multidrug-Resistant <i>Plasmodium falciparum</i>. [PDF]
Handford MJ +6 more
europepmc +1 more source
Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis. [PDF]
Edler P +47 more
europepmc +1 more source
Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria. [PDF]
Sharma R +12 more
europepmc +1 more source
Uncovering the unique characteristics of different groups of 5-HT5AR ligands with reference to their interaction with the target protein. [PDF]
Kordylewski SK +3 more
europepmc +1 more source
Efficacy and safety of pyrotinib-based regimens in patients with HER2-positive stage III/IV breast cancer: a real-world retrospective study in China. [PDF]
Zhi L, Huang L, Pang X, Wu Q, Lei Y.
europepmc +1 more source
Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia. [PDF]
Cassidy-Seyoum SA +12 more
europepmc +1 more source
Antimalarial Activity of Aqueous Extracts of Nasturtium (Tropaeolum majus L.) and Benzyl Isothiocyanate. [PDF]
Pintão AM, Santos T, Nogueira F.
europepmc +1 more source
A stage IV high-grade serous ovarian cancer patient carrying ERBB2 amplification and ERBB2 overexpression benefits from late-line pyrotinib treatment: A case report. [PDF]
Zhu B, Liu Y, Li J, Yang W.
europepmc +1 more source

